Role of p53 Pathway Alterations in Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumors)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Works matching IS 00302414 AND DT 2014 AND VI 87 AND IP 4
Results: 8
1
2
Front & Back Matter.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. X, doi. 10.1159/000368665
- Publication type:
- Article
3
Role of p53 Pathway Alterations in Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumors).
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 193, doi. 10.1159/000363574
- By:
- Publication type:
- Article
4
The High-Sensitivity Modified Glasgow Prognostic Score Is Superior to the Modified Glasgow Prognostic Score as a Prognostic Predictor in Patients with Resectable Gastric Cancer.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 205, doi. 10.1159/000362601
- By:
- Publication type:
- Article
5
Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 215, doi. 10.1159/000362603
- By:
- Publication type:
- Article
6
Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 224, doi. 10.1159/000364880
- By:
- Publication type:
- Article
7
Nilotinib in Combination with Carboplatin and Paclitaxel Is a Candidate for Ovarian Cancer Treatment.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 232, doi. 10.1159/000363656
- By:
- Publication type:
- Article
8
The Impact of a Tumor Diagnosis on Patients' Attitudes toward Advance Directives.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 246, doi. 10.1159/000363508
- By:
- Publication type:
- Article